Table 2.
In vivo biodistribution results of [18F]F-PSMA-617-NODA ([18F]1) and [18F]F-PSMA-617-RESCA ([18F]2) derivatives
| Tissue (SUV mean) | [18F]F-PSMA-617-NODA ([18F]1) (n = 3) | [18F]F-PSMA-617-RESCA ([18F]2) (n = 3) | ||||
|---|---|---|---|---|---|---|
| 10’ | 60’ | 120’ | 10’ | 60’ | 120’ | |
| Muscle | 0.14 ± 0.01 | 0.07 ± 0.01 | 0.03 ± 0.01 | 0.19 ± 0.05 | 0.12 ± 0.02 | 0.11 ± 0.04 |
| Heart | 0.26 ± 0.05 | 0.10 ± 0.03 | 0.04 ± 0.002§ | 0.35 ± 0.05 | 0.17 ± 0.03 | 0.11 ± 0.03 |
| Liver | 0.22 ± 0.01§ | 0.11 ± 0.01 | 0.05 ± 0.01 | 0.98 ± 0.15 | 0.65 ± 0.22 | 0.30 ± 0.11 |
| Kidney | 13.11 ± 1.60§ | 13.32 ± 2.23 | 9.30 ± 3.60 | 6.92 ± 1.16 | 10.21 ± 0.80 | 10.64 ± 1.25 |
| Salivary gland | 0.54 ± 0.17 | 0.24 ± 0.09§ | 0.08 ± 0.04§ | 0.54 ± 0.14 | 0.45 ± 0.10 | 0.28 ± 0.10 |
| Lung | 0.20 ± 0.04 | 0.09 ± 0.04§ | 0.04 ± 0.01§ | 0.31 ± 0.01 | 0.19 ± 0.04 | 0.12 ± 0.03 |
| Small instestine | 0.32 ± 0.05 | 0.25 ± 0.06§ | 0.15 ± 0.06§ | 1.99 ± 1.44 | 3.07 ± 1.02 | 5.79 ± 2.07 |
| Colon | 0.37 ± 0.08 | 0.27 ± 0.13 | 0.16 ± 0.03 | 0.29 ± 0.23 | 0.78 ± 1.05 | 3.87 ± 5.37 |
| Bone | 0.18 ± 0.09 | 0.13 ± 0.08 | 0.12 ± 0.09 | 0.21 ± 0.03 | 0.20 ± 0.07 | 0.15 ± 0.11 |
| Gall bladder | 0.33 ± 0.11 | 0.10 ± 0.03 | 0.04 ± 0.01 | 3.28 ± 3.18 | 5.22 ± 4.23 | 5.07 ± 4.26 |
| Brain | 0.06 ± 0.01 | 0.03 ± 0.01§ | 0.02 ± 0.01§ | 0.09 ± 0.02 | 0.07 ± 0.02 | 0.07 ± 0.01 |
§p versus [18F]PSMA-617-RESCA
Data are reported as SUV mean of respective regions of interest. Average values ± SD (§, p < 0.05 by unpaired t test) were calculated per group at 10, 60 and 120 min